王维蓉，医学博士，副教授，博士生导师
研究领域或方向
1. 心血管疾病发生发展机制
2. 心血管疾病表观遗传学调控
3. 心血管疾病药物治疗
? 招收病理学与病理生理学专业的硕士和博士研究生。
? 招收与医学、药学、护理、生物医学等相关学科的推免生。
工作简历
2009-2013，博士，药理学，西安交通大学
2013-2017，讲师，博士后，西安交通大学
2016-2017，访问****，病理系，美国华盛顿大学
2017-至今，副教授、西安交通大学
2019-至今，博士生导师，西安交通大学
科研项目
先后主持国家及省部级、校级基金项目8项，其中主持国家自然科学基金2项，中国博士后基金特别资助1项，中国博士后面上项目1项，省部级基金4项。指导大学生创新实验项目4项及开放性实验1项。参与多项国家自然科学基金、省市及横向基金的研究。
1. 国家自然科学基金面上项目，组蛋白去乙酰化酶HDAC3去巴豆酰化修饰对动脉粥样硬化中EndMT的调控及机制，在研，主持
2. 陕西省自然科学基金，组蛋白去乙酰化酶HDAC3对动脉粥样硬化EndMT调控研究，在研，主持
3. 国家自然科学基金青年科学基金项目，miR-145通过SIRT1调控血管内膜增生过程中平滑肌细胞自噬的研究，已结题，主持
学术科研
主要从事心血管疾病的发生机制及防治方面的研究，已经发表SCI论文40多篇，其中以第一或通讯作者发表SCI收录论文13篇，参编教材5部，参与授权专利多项。曾在美国华盛顿大学进行访学研究。担任中国药理学会生化与分子药理学专业委员会青年委员、中国药理学会抗炎免疫药理专业委员会青年委员、陕西省药理学会生化与分子药理学专业委员会常务委员。现任中国临床药理学与治疗学青年编委，获得中国药理学会颁发的青年药理学工作者奖。
代表性论文
1.Weirong Wang, Lifang Chen, Chenxu Shang et al. miR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy. Journal of Cellular and Molecular Medicine, 2020, 12:6658-6669
2.Weirong Wang, Chenxu Shang, Wei Zhang, et al. Hydroxytyrosol NO regulates oxidative stress and NO production through SIRT1 in diabetic mice and vascular endothelial cells. Phytomedicine, 2019, 52:206-215.
3. Yanxiang Li, Feng Yao, Chenxu Shang, Feng Ren, Jiye Zhang, Yanan Li, Yang, Guangde Yang, Rong Lin,Weirong Wang*. Preparation, characterization and in vivo evaluation of pharmacological activity of different crystal forms of ibuprofen. Pakistan Journal of Pharmaceutical Sciences, 2019, 32(5):2139-2147.
4.Weirong Wang, Yulong Chen, Liang Bai et al. Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response. Scientific Reports, 2018, 8(1):6437.
5.Weirong Wang, Ting Jing, Xiaofeng Yang et al. Hydroxytyrosol regulates the autophagy of vascular adventitial fibroblasts through SIRT1-mediated signaling pathway. Canadian Journal of Physiology and Pharmacology, 2018, 96(1):88-96.
6.Weirong Wang, Tingting Li, Ting Jing et al. SIRT1 regulates the inflammatory response of vascular adventitial fibroblasts through autophagy and related signaling pathway. Cellular Physiology and Biochemistry, 2017, 41(2):569-582.
7.Weirong Wang, Enqi Liu, Jiye Zhang et al. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1. Experimental Cell Research, 2015, 338(1):54-63.
8.Weirong Wang, Jianfeng Zhang, Yanxiang Li et al. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1. Cancer Letters, 2015, 356(2 Pt B): 791-799.
9.Weirong Wang, Ling Bai, Hu Qiao et al. The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells. Inflammation, 2014, 37(1):177-185.
10.Weirong Wang, Qinqin Lin, Rong Lin et al. PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway. Experimental Cell Research, 2013, 319(10):1523-1533.
11.Weirong Wang, Chunfang Yan, Jiye Zhang et al. SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis, 2013, 18(6):689-701.
12.Weirong Wang, Rong Lin, Jiye Zhang et al. Involvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium. Human & Experimental Toxicology, 2012, 31(11):1092-1101.
13.Weirong Wang, Rong Lin, Hui Zhang et al. The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease. Journal of Ethnopharmacology, 2011, 137(1): 214-220.
14. 陈力方，王博，王维蓉*。组蛋白去乙酰化酶3在心血管疾病中的研究进展。中国临床药理学与治疗学. 2021, 26(1):88-97.
联系方式
联系电话：**
Email: szb**@xjtu.edu.cn
联系地址：陕西省西安市雁塔区雁塔西路76号
个人主页：http://gr.xjtu.edu.cn/web/szb**